Plus-size clothing specialists City Chic Collective (ASX: CCX) has completed its departure from the US market having settled its divestment of its Avenue business to FullBeauty Brands, ending a troublesome period where marketing tailwinds were curbed by the pandemic and rise of online shopping.
This strategic divestment is part of a business restructure by City Chic, announced last month, to focus on its core customer base in Australia and New Zealand.
The sale was valued at approximately USD $12 million (approx AUD $18 million), with all conditions satisfied, allowing for a smooth transition of Avenue to FullBeauty Brands.
While the sale addresses some of City Chic’s cash flow issues, addressing their debt situation is still a key priority to turning the business around. Subsequently, City Chic’s lender agreed to restructure the Company’s debt facility, introducing a USD $10 million multi-currency facility with an extended maturity date to December 2026. This financial manoeuvre is part of a broader restructuring effort to fortify the company’s financial foundation amid declining sales and profitability.
The divestment comes as City Chic contends with a challenging market environment. The Company has reported a forecasted 30% drop in sales for FY24, bringing expected revenue to $187 million, inclusive of Avenue. Moreover, the FY24 forecasted Pro Forma Adjusted EBITDA from Continuing Operations (excluding Avenue and Evans) indicates a projected loss of $9.3 million. These figures highlight the pressing need for City Chic to recalibrate its business strategy and streamline operations of the Company that is best known to consumers seeking plus-size clothing that is both fashionable and affordable.
Seeking capital from shareholders, City Chic currently has an Entitlement Offer currently open to eligible shareholders who can purchase 1 new CCX share for every 2.04 CCX share they hold at an Offer Price of $0.15 per New Share.
City Chic is hoping to raise $8.4 million, of which $2.9 million is underwritten by Canaccord but may struggle if CCX shares continue trading at their current price of $.125.
Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…
The June 2025 quarter CPI data released today were cheered by mortgage holders and share…
AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…
Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…
Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…
In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…
View Comments
Thank you for sharing! To explore further
https://www.360iresearch.com/library/intelligence/breathable-protective-clothing